The most lethal strain could be eliminated by 2030, but major hurdles remain.

Novartis and Broad Institute researchers explore how gut bacteria contribute to health and disease, beginning with type 1 diabetes.

Pneumonia causes around 2 million child deaths per year globally and the burden is especially heavy in a country like Bangladesh, where a third of the population is aged 14 or below.

Bringing healthcare closer to where people live, work and shop can effectively tackle hypertension – the most deadly noncommunicable disease.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.

Novartis team perseveres to develop more personalized approach to breast cancer therapy.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Novartis investigators find genetic explanations for why some young patients relapse.

Combination of two compounds shows promise in the lab